Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine

Bibliographic Data

ID11025540
AuthorsShannon Stokley (At the time of the study, all of the authors were with the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.), Kate M Shaw (0000-0002-1087-2457, At the time of the study, all of the authors were with the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.), Lawrence Barker (At the time of the study, all of the authors were with the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.), Jeanne M Santoli (At the time of the study, all of the authors were with the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.), Abigail Shefer (0000-0002-5337-2807, At the time of the study, all of the authors were with the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.)
Year2006
Volume96
Issue7
Pages1308-1313
Publication date2006-07-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2004.057810
PMID16735626
PMCIDPMC1483861
OpenAlexW2067223888
LanguageEN
Citations received2
References cited23

Objective. We examined heptavalent pneumococcal conjugate vaccine (PCV7) uptake among children aged 19 to 35 months in the United States and determined how uptake rates differed by state vaccine financing policy. Methods. We analyzed data from the 2001–2003 National Immunization Survey. States that changed their vaccine financing policy between 2001 and 2003 (n=17) were excluded from analysis. Logistic regression was performed to identify the association between state vaccine financing policy and receipt of 3 or more doses of PCV7 after control for demographic characteristics. Results. The proportion of children receiving 3 or more doses increased from 6.7% in 2001 to 69.0% in 2003. After controlling for demographic characteristics, children residing in states that provided all vaccines except PCV7 to all children had lower odds of receiving 3 or more doses compared to children residing in states that provided PCV7 only to children eligible for the Vaccines for Children program (odds ratio=0.58; 95% confidence interval=0.51, 0.66). Conclusion. It is essential that we continue to monitor the effect that state vaccine financing policy has on the delivery of PCV7 and future vaccines, which are likely to be increasingly expensive

Antibiotics · Antigen · Biology · Environmental health · Immunization · Meningococcal vaccine · Pneumococcal conjugate vaccine · Streptococcus pneumoniae · Vaccination · Advanced Causal Inference Techniques · Immunology · Medicine · Microbiology · Pneumonia and Respiratory Infections · Respiratory viral infections research · Virology

Tools

Open DOISci-HubOpen Access